Skip to main content
Daan Gene Co., Ltd. logo

Daan Gene Co., Ltd. — Investor Relations & Filings

Ticker · 002030 ISIN · CNE000001KP1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,189 across all filing types
Latest filing 2025-06-09 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002030

About Daan Gene Co., Ltd.

https://www.daangene.com

Daan Gene Co., Ltd. specializes in the development and manufacturing of molecular diagnostic products and services. The company focuses on in vitro diagnostic technologies, particularly polymerase chain reaction (PCR) platforms. Its product portfolio includes diagnostic kits for infectious diseases, genetic screening, and oncology, alongside automated nucleic acid extraction systems and real-time PCR instruments. Daan Gene provides comprehensive solutions for clinical laboratories and public health institutions, integrating research, production, and clinical testing services. The organization emphasizes technological innovation in molecular biology to support precision medicine and disease control.

Recent filings

Filing Released Lang Actions
关于取得一个医疗器械注册证的提示性公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (519 characters) about the company obtaining a medical device registration certificate from the National Medical Products Administration. It is a regulatory update about a product approval, not a financial report or detailed filing. It does not contain financial data, management changes, voting results, or other report types. It is a regulatory announcement informing investors about a new product registration and associated risks. Given the short length and nature, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2025-06-09 Chinese
关于全资子公司收到现金分红款的公告
Notice of Dividend Amount Classification · 95% confidence The document is a short announcement (530 characters) regarding the receipt of a cash dividend by a wholly-owned subsidiary from an investee company. It details the dividend amount and its impact on consolidated net profit. There is no detailed financial report or comprehensive data, only a notification of dividend receipt. This fits the category of a Notice of Dividend Amount (DIV), as it announces dividend payment details relevant to shareholders and financial reporting.
2025-05-29 Chinese
第九届董事会2025年第一次临时会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of resolutions passed at the company's 2025 first extraordinary meeting of the ninth board of directors. It details election and appointment of board chairman, vice chairman, general manager, deputy general managers, and other senior management positions. The document includes voting results and references to further details published elsewhere. It does not contain financial data or detailed management discussion but focuses on board and senior management changes. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a report or a notice of report publication, so it is not an Annual Report or Report Publication Announcement.
2025-05-27 Chinese
关于董事会完成换届选举并聘任高级管理人员、证券事务代表等人员的公告
Board/Management Information Classification · 100% confidence The document is an announcement from Guangzhou Da An Gene Co., Ltd. regarding the completion of the board of directors' re-election and the appointment of senior management personnel and securities affairs representatives. It details the composition of the new ninth board, the specialized committees, and the biographies of the newly appointed directors and senior management. There is no financial data, earnings information, or report content. The document is a formal disclosure about changes in the company's board and management personnel, consistent with announcements about board/management changes. Therefore, it fits the category of Board/Management Information (MANG). The document length is sufficient and contains detailed personnel information, confirming it is not a brief notice or a report publication announcement.
2025-05-27 Chinese
2025年第二次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2025 second extraordinary shareholders' meeting of Guangzhou Da An Gene Co., Ltd. It includes information about the meeting's time, location, voting methods, attendance, and detailed voting results for the nomination of board directors. It also includes legal opinions confirming the legality and validity of the meeting and resolutions. The content focuses on shareholder voting results and board nominations, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4091 characters, which is sufficient to contain substantive voting results rather than just an announcement of a report. Therefore, the appropriate classification is DVA.
2025-05-26 Chinese
2025年第二次临时股东会的法律意见书
Board/Management Information Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, and results of a specific shareholders' meeting (the 2025 second extraordinary general meeting) of Guangzhou Da An Gene Co., Ltd. It details the legal compliance of the meeting's call, attendance, voting procedures, and results, including the election of board members. The document does not contain financial statements or financial performance data, nor is it a report of financial results or management discussion. It is a legal opinion related to a shareholders' meeting and the election of directors, which aligns with announcements about changes in the company's board of directors. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length (5992 characters) and content confirm it is not a brief announcement but a detailed legal opinion on board-related matters.
2025-05-26 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.